Cytokine Release Syndrome (CRS) in Patients With COVID-19-induced Pneumonia
1 clinical trials · Condition
◉ Watch Cytokine Release Syndrome (CRS) in Patients With COVID-19-induced Pneumonia
| Record | Firm | Date |
|---|---|---|
| Study of Efficacy and Safety of Canakinumab Treatment for CRS in Participants With COVID-19-induced Pneumonia (NCT04362813) | Novartis Pharmaceuticals | 2020-04-30 |
Track Cytokine Release Syndrome (CRS) in Patients With COVID-19-induced Pneumonia automatically
Every clearance here is in the API, with alerts when new ones post.